|
⚲
|
| Keyboard |
| Sargen Gregory
✚
|
|
|---|---|
| CIK # | 0001227835 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001227835] | |
| 4 | [0001227835] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sargen Gregory | |
| Proteon Therapeutics Inc | |
| Peregrine Pharmaceuticals Inc | |
| Cambrex Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 24,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2025-02-05 | Disposed to issuer | 36,368 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 19,675 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 10,030 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 8,147 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 75,000 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 19,600 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-14 | Grant | 8,147 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-14 | Option exercise | 26,756 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-14 | Option exercise | 26,756 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2024-06-07 | Grant | 10,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2023-12-14 | Option exercise | 9,612 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2023-12-14 | Grant | 26,756 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2023-12-14 | Option exercise | 9,612 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2023-06-07 | Grant | 10,000 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2023-04-11 | Sell | 7,011 | $20.24 | 141,903 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2022-12-14 | Option exercise | 4,632 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2022-12-14 | Option exercise | 4,632 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2022-12-14 | Grant | 9,612 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2022-06-08 | Grant | 10,000 | $0.00 | |
| showing 20 of 123 most recent transactions | |||||